Bafna Pharmaceuticals
₹99.6
-5.2 (-4.96%)
13 May, 2024 17:54 BSE: 532989
NSE: BAFNAPHISIN: INE878I01022
Start SIP in Bafna Pharmaceuticals
Start SIPBafna Pharmaceuticals Performance
Day Range
- Low 100
- High 100
52 Week Range
- Low 76
- High 124
- Open Price100
- Previous Close105
- Volume384
Bafna Pharmaceuticals Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 28 | 41 | 42 | 42 |
Operating Expenses Qtr Cr | 31 | 37 | 36 | 35 |
Operating Profit Qtr Cr | -2 | 4 | 6 | 8 |
Depreciation Qtr Cr | 1 | 1 | 1 | 2 |
Interest Qtr Cr | 1 | 0 | 1 | 1 |
Tax Qtr Cr | 0 | 0 | 0 | 0 |
Net Profit Qtr Cr | -3 | 2 | 6 | 5 |
Bafna Pharmaceuticals Technicals
EMA & SMA
Current Price
₹99.6
-5.2 (-4.96%)
- Bullish Moving Average
- ___
- 14
- Bearish Moving Average
- ___
- 2
- 20 Day
- ₹93.80
- 50 Day
- ₹90.75
- 100 Day
- ₹91.00
- 200 Day
- ₹92.70
- 20 Day
- ₹91.90
- 50 Day
- ₹87.73
- 100 Day
- ₹92.68
- 200 Day
- ₹92.07
Bafna Pharmaceuticals Resistance and Support
PIVOT
₹99.6
Resistance | |
---|---|
First Resistance | 99.60 |
Second Resistance | 99.60 |
Third Resistance | 99.60 |
RSI | 60.18 |
MFI | 83.33 |
MACD Single Line | 2.68 |
MACD | 4.44 |
Support | |
---|---|
First Resistance | 99.60 |
Second Resistance | 99.60 |
Third Resistance | 99.60 |
Bafna Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 22,539 | 2,253,900 | 100 |
Week | 56,771 | 5,677,050 | 100 |
1 Month | 13,634 | 1,363,413 | 100 |
6 Month | 12,021 | 1,202,128 | 100 |
Bafna Pharmaceuticals Result Highlights
Bafna Pharmaceuticals Synopsis
NSE-Medical-Generic Drugs
Bafna Pharmaceutical belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 115.35 Cr. and Equity Capital is Rs. 23.66 Cr. for the Year ended 31/03/2023. Bafna Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 28/03/1995 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24294TN1995PLC030698 and registration number is 030698.Market Cap | 236 |
Sales | 153 |
Shares in Float | 0.28 |
No of funds | |
Yield |
Book Value | 3.38 |
U/D Vol ratio | 1.4 |
LTDebt / Equity | 11 |
Alpha | 0.02 |
Beta | 0.32 |
Bafna Pharmaceuticals
Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|---|
Promoters | 88.3% | 88.43% | 88.74% | 90% |
Individual Investors | 7.47% | 7.66% | 6.87% | 5.64% |
Others | 4.23% | 3.91% | 4.39% | 4.36% |
Bafna Pharmaceuticals Management
Name | Designation |
---|---|
Mrs. S Hemalatha | Chairperson & Executive Director |
Mrs. Akila C Raju | Non Exe.Non Ind.Director |
Ms. R Chitra | Ind. Non-Executive Director |
Mr. B Kamlesh Kumar | Ind. Non-Executive Director |
Mr. P K Sundaresan | Ind. Non-Executive Director |
Bafna Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Bafna Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-02-12 | Quarterly Results | |
2023-11-09 | Quarterly Results | |
2023-08-11 | Quarterly Results | |
2023-05-27 | Audited Results | (Revised) |
2023-04-07 | Others |
Bafna Pharmaceuticals FAQs
What is Share Price of Bafna Pharmaceuticals ?
Bafna Pharmaceuticals share price is ₹99 As on 13 May, 2024 | 17:40
What is the Market Cap of Bafna Pharmaceuticals ?
The Market Cap of Bafna Pharmaceuticals is ₹235.6 Cr As on 13 May, 2024 | 17:40
What is the P/E ratio of Bafna Pharmaceuticals ?
The P/E ratio of Bafna Pharmaceuticals is 20.9 As on 13 May, 2024 | 17:40
What is the PB ratio of Bafna Pharmaceuticals ?
The PB ratio of Bafna Pharmaceuticals is 3.2 As on 13 May, 2024 | 17:40